USE OF SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF VISCERAL PAIN OR PAIN CAUSED BY CANCER TREATMENT
申请人:Wex Pharmaceuticals Inc.
公开号:EP1928452A2
公开(公告)日:2008-06-11
USE OF SODIUM CHANNEL BLOCKERS FOR THE MANAGEMENT OF MUSCULOSKELETAL PAIN
申请人:Wex Pharmaceuticals Inc.
公开号:EP1931349A2
公开(公告)日:2008-06-18
EP1931349A4
申请人:——
公开号:EP1931349A4
公开(公告)日:2009-08-05
Use of sodium channel blockers for the management of musculoskeletal pain
申请人:Fisher Kim Noel
公开号:US20100048592A1
公开(公告)日:2010-02-25
The invention provides methods for managing musculoskeletal pain. The compounds useful in the methods of the invention are blockers of sodium ion channels, and in particular compounds that bind to the SS1 or SS2 extracellular mouth of the a-subunit thereof. Particularly useful compounds are saxitoxin and its derivatives and analogues and tetrodotoxin and its derivatives and analogues.
Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment
申请人:Fisher Kim Noel
公开号:US20100144767A1
公开(公告)日:2010-06-10
The invention provides methods for treating visceral pain and pain associated with therapy. The compounds useful in the methods of the invention are blockers of sodium ion channels, and in particular compounds that bind to the SS1 or SS2 extracellular mouth of the α-subunit thereof. Particularly useful compounds are saxitoxin and its derivatives and analogues and tetrodotoxin and its derivatives and analogues.